Resources
References
-
World Health Organization Regional Office for Europe. Action plan for the health sector response to viral hepatitis in the WHO European Region. Copenhagen: WHO Europe; 2016.
-
World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Geneva: WHO; 2021.
-
Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013; 58(3): 593-608
-
European Centre for Disease Prevention and Control. Hepatitis B. In: ECDC. Annual epidemiological report for 2020. Stockholm: ECDC; 2022.
Available at: https://www.ecdc.europa.eu/en/publicationsdata/hepatitis-b-annual-epidemiological-report-2020 -
European Centre for Disease Prevention and Control. Systematic review on hepatitis B and C prevalence in the EU/EEA. Stockholm: ECDC; 2016.
Available at: https://www.ecdc.europa.eu/en/publicationsdata/systematic-review-hepatitis-b-and-c-prevalence-eueea -
ECDC HCV prevalence estimates (collected as part of the HCV modelling project – work currentlyunpublished).
-
Mårdh O, Quinten C, Amato-Gauci AJ, Duffell E. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA – descriptive analysis and estimation of 2015 baseline. Infectious Diseases. 2020; 52(9): 625-37.
-
Bivegete S TA, Thornton Z, Scanlan B, McNaughton AL, Lim AG et al. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review. [Submitted for peer review publication 2022.]
-
European Centre for Disease Prevention and Control. Hepatitis C. In: ECDC. Annual epidemiological report for 2020. Stockholm: ECDC; 2022.
Available at: https://www.ecdc.europa.eu/en/publicationsdata/hepatitis-c-annual-epidemiological-report-2020 -
Mason L, Duffell E, Veldhuijzen IK, Petriti U, Bunge EM, Tavoschi L. Hepatitis B and C prevalence and incidence in key populations group with multiple risk factors in the EU/EEA: a systematic review. Eurosurveillance. 2019; 24(30): 1800614.
Available at: https://doi.org/10.2807/1560-7917.ES.2019.24.30.1800614 -
Chiappini E, Parigi S, Galli L, Licari A, Brambilla I, Tosca MA, Ciprandi G, Marseglia G. Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: a narrative review. ACTA Paediatrica. 2021; 110(9): 2529 – 2535.
-
Huss G, Magendie C, Pettoello-Mantovani M, Jaeger-Roman E. Implications of the COVID-19 pandemic for pediatric primary care practice in Europe. European Paediatric Association. 2021; 233: 290 – 291.
-
World Health Organization. WHO/UNICEF estimates of national immunization coverage. Geneva, Switzerland: WHO; 2021. https://www.who.int/teams/immunization-vaccines-andbiologicals/immunization-analysis-and-insights/global-monitoring/immunization-coverage/who-unicefestimates-of-national-immunization-coverage
-
European Monitoring Centre for Drugs and Drug Addiction. Elimination barometer on viral hepatitis among people who inject drugs in Europe. Luxembourg: EMCDDA; 2021 [14 June 2022].
Available at: https://www.emcdda.europa.eu/publications/html/viral-hepatitis-elimination-barometer_en -
EDQM (Council of Europe). The collection, testing and use of blood and blood components in Europe: 2016 report. Strasbourg, France: EDQM Publishers; 2021.
-
Rockstroh JK, Boesecke C. Hepatitis C virus treatment as prevention: Challenges and opportunities in men who have sex with men. The Journal of Infectious Diseases. 2020; 222(S9): S782 – S788.
-
Lafferty L, Rance J, Dore GJ, Grebely J, Lloyd AR, Treloar C. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel. International Journal of Drug Policy. 2021; 98: 103379.
-
Leask JD, Dillon JF. Review Article: Treatment as prevention – targeting pathway towards hepatitis C eradication. Alimentary Pharmacology and Therapeutics. 2016; 44: 145 – 156.
-
Braun DL, Hampel B, Ledergerber B, et al. A treatment-as-prevention trial to eliminate hepatitis C among men who have sex with men living with human immunodeficiency virus (HIV) in the Swiss HIV cohort study. Clinical Infectious Diseases. 2021; 73(7): e2194 – e2202.
-
Rigoni R, Tammi T, van der Gouwe D, Moura J, Prins-Schiffer K. Civil society monitoring of harm reduction in Europe, 2021. Data Report. Amsterdam: Correlation – European Harm Reduction Network; 2022.
-
European Centre for Disease Prevention and Control. Monitoring of responses to the hepatitis B and C epidemics in EU/EEA countries – 2020 data. Stockholm: ECDC; 2022.
Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Monitoring-responses-to-hepatitis-B-and-Cepidemics-2020-data.pdf -
The EMIS Network. EMIS-2017 – The European Men-Who-Have-Sex-With-Men Internet Survey. Key Findings from 50 Countries. Stockholm: European Centre for Disease Prevention and Control; 2019.
Acknowledgements
This report was produced by Katherine Turpie (National AIDS Trust) and Erika Duffell (European Centre for Disease Prevention and Control). The authors would like to thank the following individuals for their invaluable input in providing data and in reviewing the document:
-
Austria
Ziad El-Khatib
Irene Kászoni-Rückerl
Sigrid Kiermayr
Anna Nagel
Maria Paulke-Korinek
Elise Schabus
Irrene Schmuttere
Margit Winterleitner
-
Belgium
Benoit Kabamba
Sofieke Klamer
Els Plettinckx
Michael Peeters
Dominique van Beckhoven
Thomas Vanwolleghem
-
Bulgaria
Mariya Tyufekchieva
Tonka Varleva
-
Croatia
Maja Ilic
Tatjana Nemeth-Blažić
Adriana Vince
-
Cyprus
Fani Theophanous
-
Czechia
Jitka Cástková
Vratislav Nĕmeček
-
Denmark
Peer Brehm Christensen
Susan Cowan
Martine Grosos Aabye
Anne Øvrehus
-
Estonia
Jevgenia Epštein
Kristi Rüütel
-
Finland
Henrikki Brummer
Kirsi Liitsola
Henna Rautiainen
Päivi Viitanen
-
France
Cécile Brouard
Mathias Bruyand
Florcence Lot
Joisane Pillonel
-
Germany
Sandra Dudavera
Gyde Steffen
Ida Sperle-Heupel
Ruth Zimmermann
-
Greece
Stergios Georgoulas
Georgia Nikolopoulou
George Papatheodoridis
Ioanna Samiou
Panagiota Touloumi
Sois Zoutsos
-
Hungary
Agnes Danielisz
Maria Dudas
Emese Kozma
Zsuzsanna Molnár
-
Iceland
Guðrún Aspelund
Már Kristjánsson
-
Ireland
Jeff Connell
Suzanne Cotter
Cillian De Gascun
Joanne Moran
Aiden McCormick
Niamh Murphy
Aisling O'Leary
Mary O’Riordan
-
Italy
Loreta Kondili
Francesco Maraglino
Barbara Suligoi
Maria Elena Tosti
Sabrina Valle
-
Latvia
Inga Ažiņa
Raina Nikiforova
Serges Nikisins
-
Liechtenstein
Silvia Dehler
Esther Walser-Domjan
-
Lithuania
Brigita Kairiene
-
Luxembourg
Carole Devaux
-
Malta
Jackie Melillo
Tanya Melill
-
The Netherlands
Silke David
Jaap Maas
Annemarie Meiberg
Eline Op de Coul
Marleen van Dijk
Irene Veldhuijzen
-
Norway
Hilde Kløvstad
-
Poland
Robert Flisiak
Małgorzata Stępień
Karolina Zakrzewska
-
Portugal
Joana Bettencourt
Rui Tato Marinho
Sofia Ribeiro
-
Romania
Odette Popovici
Corina Silvia Pop
-
Slovakia
Mária Avdicová
-
Slovenia
Marta Grgič-Vitek
Jože Hren
Irena Klavs
Janja Križman Miklavčič
Eva Leban
Mojca Matičič
Mario Poljak
Urška Rahne Potokar
-
Spain
Agustín Albillos
Maria Buti
Javier Crespo
Julia del Amo
Asunción Diaz
José Luis Calleja
Javier GarcíaSamaniego
Victoria Hernando
Oriana Ramírez-Rubio
Pablo Ryan
-
Sweden
Soo Aleman
Maria Axelsson
Hanna Edberg
Josefine Lundberg Ederth
Martin Kåberg
-
ECDC
Lina Nerlander
Teymur Noori
-
European Monitoring Centre for Drugs and Drug Addiction
Thomas Seyler
-
WHO Regional Office for Europe
Giorgi Kuchukhidze
Antons Mozalevskis